Liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients with hepatocellular carcinom; 2. age 42-76; 3. lesion diameter 1-10.8cm.
Exclusion criteria
Exclusion criteria: 1. other parts of the coexistence of tumor; 2. tumor could not be complete ablation by once; 3. during the study period with severe liver and kidney dysfunction, coagulation disorders and diseases of the immune system; 4. patients had received operation, intervention, radiotherapy, chemotherap, immune enhancement agen before and after the treatment of 1 months; 5. participating in other clinical trials of patient; 6. the researchers believe that any reason will causes the patients to be unsuitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| regulatory T cell;natural killer cell;CD4+ T cell;CD8+ T cell;TNF-alpha;IFN-gama;IL-2;IL-4;IL-6;IL-8;IL-10;IL-12; | — |
Countries
China